The CET leverages ultrasound to penetrate tissues, enabling quick imaging of the human body. Credit: Gorodenkoff / Shutterstock.com.

CET利用超声波穿透组织，从而实现对人体的快速成像。图片来源：Gorodenkoff / Shutterstock.com。

Maui Imaging has secured $14m in a Series D financing round, including equity funding, for supporting the manufacturing, sales, and marketing efforts of its computed echo tomography (CET)-based imaging technology.

Maui Imaging公司在D轮融资中筹集了1400万美元，包括股权融资，以支持其基于计算回声断层扫描（CET）的成像技术的生产、销售和营销工作。

Acertara Acoustic Laboratories spearheaded the funding round.

Acertara声学实验室牵头了这轮融资。

Go deeper with GlobalData

深入了解更多GlobalData信息

Reports

报告

China General Surgery Market Outlook to 2025 - Access Instruments, ...

中国普通外科市场展望至2025年 - 介入器械，...

Reports

报告

France General Surgery Market Outlook to 2025 - Access Instruments,...

法国普通外科市场展望至2025年 - 通路器械，...

Data Insights

数据洞察

The gold standard of business intelligence.

商业智能的黄金标准。

Find out more

了解更多信息

The CET leverages ultrasound to penetrate tissues, enabling quick imaging of the human body. It is protected by more than 160 patents.

CET利用超声波穿透组织，实现对人体的快速成像。它受到160多项专利的保护。

The company is now advancing to the commercial stage with devices being delivered to initial users.

公司现在正向商业阶段迈进，并开始向首批用户交付设备。

Acertara has taken the lead in pre-orders and holds exclusive distributorship rights in the US for hospitals not served directly by Maui Imaging.

Acertara在预购中处于领先地位，并在美国拥有Maui Imaging未直接服务的医院的独家经销权。

Acertara Acoustic Labs president and CEO Levi Moore said: “The MAUI ultrasound system represents a major advancement in medical imaging. By reducing the complexity of image acquisition and offering an intuitive approach, it expands ultrasound’s reach to new users and clinical settings.

Acertara声学实验室总裁兼首席执行官Levi Moore表示：“MAUI超声系统代表了医学影像领域的重大进步。通过简化图像采集的复杂性并提供直观的方法，它将超声的应用扩展到了更多新用户和临床环境中。”

GlobalData Strategic Intelligence

全球数据战略情报

US Tariffs are shifting - will you react or anticipate?

美国关税正在变化——你会做出反应还是提前预测？

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

不要让政策变化让你措手不及。通过实时数据和专家分析保持主动性。

By GlobalData

全球数据

Learn more about Strategic Intelligence

了解有关战略情报的更多信息

“We’re working closely with MAUI to accelerate adoption in hospitals nationwide, where this technology has the potential to save lives and significantly improve patient outcomes.”

“我们正在与MAUI密切合作，加速在全国医院推广这项技术，它有潜力挽救生命并显著改善患者疗效。”

In October 2023, the MAUI K3900 ultrasound imaging system secured 510(k) clearance from the US Food and Drug Administration (FDA).

2023年10月，MAUI K3900超声成像系统获得了美国食品药品监督管理局（FDA）的510(k)许可。

It is designed for a wide range of diagnostic applications, including abdominal, foetal, paediatric, and cardiac imaging.

它设计用于广泛的诊断应用，包括腹部、胎儿、儿科和心脏成像。

Maui Imaging’s diagnostic imaging approach offers a blend of ultrasound and CT capabilities without the risks associated with ionising radiation.

Maui Imaging的诊断成像方法结合了超声波和CT功能，且没有电离辐射带来的风险。

The company leverages algorithms that process the reflected energy from different angles and compile the information to generate accurate images of the body’s interior. This method allows the imaging system to incorporate common impediments such as bone, gas, fat, medical instruments, and implants into the final image, rather than allowing them to hinder the imaging process..

公司利用算法处理从不同角度反射的能量，并将信息编译生成精确的人体内部图像。这种方法使成像系统能够将常见的障碍物（如骨骼、气体、脂肪、医疗器械和植入物）纳入最终图像，而不是让它们阻碍成像过程。

Maui Imaging is actively conducting clinical trials with military partners and other organisations to validate this technology.

Maui Imaging正在与军事合作伙伴及其他组织积极进行临床试验，以验证该技术。

Last year, Maui Imaging came out of stealth mode,

去年，毛伊成像公司退出了隐身模式，

announcing a $4m deal

宣布了一项400万美元的交易

with the US Department of Defense to support trauma response initiatives using its ultrasound device. This deal involved the MAUI K3900 system.

与美国国防部合作，利用其超声波设备支持创伤响应计划。这笔交易涉及MAUI K3900系统。

Sign up for our daily news round-up!

注册获取我们的每日新闻汇总！

Give your business an edge with our leading industry insights.

利用我们领先的行业洞察，为您的业务提供优势。

Sign up

注册

Medical Device Network Excellence Awards - The Benefits of Entering

医疗器械网络卓越奖——参赛的好处

Gain the recognition you deserve! The

获得你应得的认可！

Medical Device Network Excellence Awards

医疗器械网络卓越奖

celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

庆祝创新、领导力和影响力。通过参赛，您将展示自己的成就，提升行业形象，并将自己置于推动医疗器械进步的顶尖领导者之列。不要错过脱颖而出的机会——立即提交您的参赛作品！

Nominate Now

立即提名

Share

分享

Copy Link

复制链接

Share on X

分享到X

Share on Linkedin

分享到领英

Share on Facebook

分享到 Facebook